An agent indicated for the treatment of chorea associated with huntington’s disease. Marketed under the brand name xenazine.
A drug used mainly to control disorders of movement in Huntington’s chorea and similar disorders. It probably acts by reducing dopamine at the nerve endings, thus slowing neural transmissions.